IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis

J Cyst Fibros. 2012 May;11(3):193-200. doi: 10.1016/j.jcf.2011.11.007. Epub 2011 Dec 16.

Abstract

Nasal polyps in adults are characterized by a chronic inflammation of the upper airways and by the preferential activation of Th2 cells. In contrast, IL-17 producing Th17 cells dominate the inflammation in nasal polyps of cystic fibrosis (CF) patients.

Method: IL-17A, IL-5, IL-6, IL-8, IL-1β, ECP, MCP-1 and myeloperoxidase expression was determined in tissue homogenates of nasal polyps of non-CF and CF patients and controls. The cellular source of IL-17A was determined by immuno-histochemistry and FACS analysis. The functional role of IL-17A in the survival of neutrophils from CF and non-CF patients was tested.

Results: A significant upregulation of IL-17A and myeloperoxidase could be observed in nasal polyps from CF-patients. The cellular sources of IL-17A in nasal polyps were mainly T-lymphocytes. IL-17A was able to modulate the survival of neutrophils in nasal polyps from non-CF patients; however the survival of neutrophils in CF patients was independent of IL-17A.

Conclusion: The present study shows that IL-17A has an impact on neutrophil survival in adult nasal polyp disease, but not in nasal polyps from CF patients.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cell Survival
  • Cells, Cultured
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / metabolism*
  • Cystic Fibrosis / pathology
  • Humans
  • Immunohistochemistry
  • Interleukin-17 / metabolism*
  • Intracellular Fluid / metabolism
  • Nasal Mucosa / metabolism
  • Nasal Mucosa / pathology
  • Nasal Polyps / complications
  • Nasal Polyps / metabolism*
  • Nasal Polyps / pathology
  • Neutrophils / metabolism
  • Th17 Cells / metabolism

Substances

  • Interleukin-17